Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-6583.8%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 1.96Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information
Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMEREO BIOPHARMA GROUP PLC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MREO - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -32.92M | -6583.8% | $ 500K |
| 3/31/2025 | $ -33.17M | 0% | $ 0 |
| 12/31/2024 | $ -32.83M | 0% | $ 0 |
| 6/30/2024 | $ -20.45M | -1876.1% | $ 1.09M |
| 12/31/2023 | $ -21.13M | -211.32% | $ 10M |
| 6/30/2023 | $ -41.59M | -466.84% | $ 8.91M |
| 12/31/2022 | $ -48.52M | 0% | $ 0 |
| 6/30/2022 | $ -42.43M | 0% | $ 0 |
| 12/31/2021 | $ -6.55M | -14.37% | $ 45.58M |
| 6/30/2021 | $ -9.1M | -19.97% | $ 45.58M |
Key Performance Insights, Last 5 Years
- MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) OCF % stands at 0%.
- Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average OCF % has been -1528.73%.
- The median OCF % for MEREO BIOPHARMA GROUP PLC during this period was -339.08%
- MEREO BIOPHARMA GROUP PLC reached its highest OCF % over the past 5 years at -14.37%.
- The lowest OCF % recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe -6583.8%
MEREO BIOPHARMA GROUP PLC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for MEREO BIOPHARMA GROUP PLC is calculated as follows: CF - Operations [ $ -35.43M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ] MREO - Operating Cash Flow Margin, Last 5 years
-6583.8%
Minimum
Jun 30, 2025
-14.37%
Maximum
Dec 31, 2021
-1528.73%
Average
-339.08%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.33% with a standard deviation of 21.12%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.33% |
| median | 12.67% |
| std | 21.12% |